Evermed

Evermed's entire business is that gap between "valuable" and "findable." The company, based in New York and founded around 2018, takes those conference archives and turns them into something a doctor will actually open on a phone between patients: a branded, on-demand, Netflix-style education library, with search that works and recommendations that learn what you care about.

The Netflix comparison is not something a marketing team bolted on afterward. It is the pitch. Evermed says it uses the same class of personalization technology that Netflix and YouTube use - the homepage that reshuffles itself around you, the weekly email that suggests the next three things - and points it at cardiology, pathology and allergy medicine instead of prestige television. When Novartis built an on-demand video hub for doctors, the pharma trade press called it the company's "Netflix moment." Evermed would like every medical society to have one.

What makes this more than a skin over a video player is the part nobody wants to do. Turning raw conference footage into a browsable library is unglamorous labor: tagging metadata, writing captions, cutting long sessions into watchable pieces, generating thumbnails, quality-checking the whole thing. Evermed does that as a managed service. The proposition it makes to a society is unusually blunt for enterprise software - launch a modern platform in roughly 90 days, and do it without hiring a single new person or learning what a CDN is.

That "without hiring anyone" clause is the actual product. Associations are not short on content or ambition; they are short on operational capacity. By absorbing the labor and the technology, Evermed removes the excuse that keeps these projects stuck in committee. Adoption stops being a technical question and becomes a decision someone can make.

There is also, sitting quietly underneath the mission, a revenue story - and to Evermed's credit it does not pretend otherwise. Medical societies run on membership dues and conference fees, both of which are under pressure. A content library that people actually use is a new surface to monetize: subscriptions for premium access, and sponsorships from the pharmaceutical companies that already spend heavily to reach physicians. Evermed ships monetization templates alongside the platform. The mission ("amplify medical education") and the margin ("here is a new revenue line") are pointed in the same direction, which is generally the sign of a business that can survive its own idealism.

The numbers Evermed reports from its flagship engagement, with the American College of Cardiology, are the kind that make the pitch land. Cardiologists on the ACC platform average north of 80 minutes of watch time a month. The weekly recommendation email hits a 65% open rate - a figure most consumer newsletters would frame and hang on a wall. The company cites a 4:1 return in its ACC case study. You should read vendor-supplied case-study numbers the way you read any number a company chose to publish about itself, which is to say with interest and one eyebrow raised. But the direction is clear enough, and the roster of societies signing on suggests the eyebrow can come back down.

Because the roster is the real evidence. This is not one lighthouse customer propping up a deck. The College of American Pathologists launched "CAP on Demand" - a Netflix-style pathology library - in 108 days. The American College of Emergency Physicians launched "ACEP Anytime" in 2024. EAACI, the European allergy and immunology body, launched "EAACI Nexus" in 2025. CHEST and the American Society of Anesthesiologists are on the list too. Across these libraries, clinicians from more than 120 countries have shown up to watch.

What all of this quietly amounts to is a professional association learning to behave like a media company - competing for a doctor's attention against every other thing on the same phone, and occasionally winning. That is a stranger and more interesting outcome than "vendor sells video platform," and it is roughly what Evermed set out to cause.